Posted by Michael Wonder on 04 Mar 2022
Hundreds of patients to benefit from revolutionary lung cancer drug on the NHS
3 March 2022 - A revolutionary targeted drug for lung cancer will be made available to anyone who is eligible, thanks to a new drug deal, the head of the NHS announced today.
NHS patients in England were the first in Europe to benefit from the drug in September thanks to an early access agreement made with the manufacturer.
Around 100 patients have already received the treatment.
